The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | C | Cardiovascular system | |
| 2 | C03 | Diuretics | |
| 3 | C03A | Low-ceiling diuretics, thiazides | |
| 4 | C03AA | Thiazides, plain | |
| 5 | C03AA03 | Hydrochlorothiazide |
The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.
| Route | Amount |
|---|---|
| ORAL - Oral | 25 mg |
| Active Ingredient | Description | |
|---|---|---|
| Hydrochlorothiazide |
Hydrochlorothiazide is a diuretic with antihypertensive properties. It acts by inhibiting the renal tubular re-absorption of sodium and chloride ions, which are excreted with an accompanying volume of water. Potassium excretion is also promoted. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| DIDRALIN Tablet | Υπουργείο Υγείας (CY) | MPI, EU: SmPC | |
| RIDAQ 12.5 mg Tablet | Health Products Regulatory Authority (ZA) | MPI, Generic | |
| RIDAQ 25 mg / 50 mg Tablet | Health Products Regulatory Authority (ZA) | MPI, Generic |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
